ADVENTRX Pharmaceuticals (ANX)
ADVENTRX Pharmaceuticals Income Statement
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Income | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Revenue | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Cost of Revenue | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Gross Profit | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Research & Development Expense | 2.210M | 1.754M | 2.050M | 1.343M | 0.6113M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Selling, General, & Admin. Expense | 2.045M | 1.810M | 1.982M | 1.824M | 1.574M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation & Amortization | 0.0302M | 0.0088M | 0.0085M | 0.0104M | 0.0099M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Operating Interest Expense | -0.0003M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||||
| Other Operating Income (Expense) | 0.1144M | 1.130M | 0.4878M | -1.229M | -0.7995M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Operating Expenses | 4.172M | 2.443M | 3.553M | 4.406M | 2.994M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Operating Income | -4.172M | -2.443M | -3.553M | -4.406M | -2.994M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Non-Operating Income | 0.019M | 0.0709M | 0.0138M | 0.0143M | 0.038M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Pretax Income | -4.152M | -2.372M | -3.539M | -4.392M | -2.956M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Provision for Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income after Tax | -4.152M | -2.372M | -3.539M | -4.392M | -2.956M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Equity In Affiliates | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income Before Extraordinaries & Disc. Operations | -4.152M | -2.372M | -3.539M | -4.392M | -2.956M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Investment Gains/Losses | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Income/Charges | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income from Discontinued Operations | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Income | -4.152M | -2.372M | -3.539M | -4.392M | -2.956M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Earnings Per Share Data | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Average Shares to compute diluted EPS | 47.72 | 28.18 | 26.47 | 26.25 | 22.76 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Average Shares used to compute basic EPS | 47.72 | 28.18 | 26.47 | 26.25 | 22.76 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS - Basic net | -0.09 | -0.04 | -0.13 | -0.17 | -0.13 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS - Diluted net | -0.09 | -0.04 | -0.13 | -0.17 | -0.13 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |